Company page

Abbisko Cayman Limited

Abbisko Cayman Limited, trading under the ticker 2256 on the Hong Kong market, has a market capitalization of approximately HKD 885.34 million. The company is focused on the development and commercialization of innovative therapies. Its strategic initiatives aim to address unmet medical needs in various therapeutic areas.